Mechanistic Learning for Survival Prediction in NSCLC Using Routine Blood Biomarkers and Tumor Kinetics

Ruben Taieb, René Bruno, Pascal Chanu +2

Background Predicting overall survival (OS) in non-small cell lung cancer (NSCLC) is essential for clinical decision-making and drug development. While tumor and blood test markers…